Jean M. Franchi Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jean M. Franchi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jean M. Franchi. Jean M. Franchi is a Chief Financial Officer in MERRIMACK PHARMACEUTICALS INC ($MACK) and a Chief Financial Officer in Dimension Therapeutics, Inc. ($DMTX) and a Chief Financial Officer in Replimune Group, Inc. ($REPL).
Address: C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE, 4TH FLOOR CAMBRIDGE 02139 MA
Companies in which Jean M. Franchi is an Insider
Dimension Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jean M. Franchi: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 03 2017
$DMTX Market Capitalization: $41.32M
$DMTX Previous Close: $1.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MERRIMACK PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jean M. Franchi: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2018
$MACK Market Capitalization: $405.05M
$MACK Previous Close: $3.22
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Replimune Group, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jean M. Franchi: Chief Financial Officer
Holdings: 46,035 shares
Latest Transaction: Apr 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jean M. Franchi
Sentiment: All, DMTX, MACK, REPL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Option Exercise | A | 31.58 | 69,050 | 2,180,599 | 69,050 | |
| Apr 05 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Grant | A | 0.00 | 46,035 | 0 | 46,035 | 0 to 46 K |
| Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Option Exercise | M | 14.08 | 14,900 | 209,792 | 140,000 | |
| Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Option Exercise | M | 14.08 | 100 | 1,408 | 154,900 | |
| Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Sell | S | 44.00 | 600 | 26,400 | 0 | 600 to 0 (-100.00 %) |
| Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Sell | S | 44.55 | 14,300 | 637,065 | 600 | 14.9 K to 600 (-95.97 %) |
| Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Buy | M | 14.08 | 14,900 | 209,792 | 14,900 | 0 to 14.9 K |